Partnership & Market Access

A Scientific, Structured Path into the Iranian Healthcare Market

KTD connects product understanding, regulatory pathway planning, local market realities, and commercial execution—helping international healthcare companies evaluate and pursue responsible market entry in Iran.

Discuss Market Entry Explore Our Capabilities

Why a specialized partner

Market access is more than selecting a distributor

A credible entry plan must connect the product’s scientific and professional context with regulatory requirements, commercial feasibility, and practical execution. Each opportunity carries its own constraints, dependencies, and decisions.

  • Product expertise and understanding of its professional or clinical use context
  • Regulatory pathway understanding and review of the required documentation
  • Market assessment and commercial feasibility
  • Engagement with relevant professionals, healthcare settings, and customer groups
  • Planning for importation, launch, education, distribution, and support
  • Alignment between the manufacturer’s global strategy and local market conditions

Market-entry support

How KTD supports an entry pathway

  1. Opportunity & Portfolio Assessment

    Reviewing the product, evidence context, portfolio fit, strategic objectives, and initial conditions for further evaluation.

  2. Regulatory Pathway Planning

    Mapping the likely pathway, documentation needs, responsibilities, and decision points before regulatory work is initiated.

  3. Market Intelligence & Positioning

    Examining the use context, customer groups, competing approaches, access constraints, and an appropriate local position.

  4. Distribution & Commercial Development

    Evaluating channel structure, commercial responsibilities, launch priorities, and a disciplined approach to market development.

  5. Scientific Communication & Professional Engagement

    Planning evidence-grounded communication and appropriate engagement with relevant professional communities.

  6. Localization, OEM & Technology Transfer Assessment

    Assessing whether local packaging, OEM, localization, or technology-transfer options merit deeper technical and commercial review.

  7. Post-entry Coordination & Market Development

    Coordinating agreed activities, market feedback, partner communication, and responsible development after entry.

Partnership models

Structures shaped around the product and the opportunity

  • Exclusive or Non-exclusive Distribution
  • Regulatory Representation & Market Access Support
  • Product Launch & Commercial Development
  • OEM and Local Packaging Assessment
  • Technology Transfer and Local Manufacturing Evaluation
  • Research or Scientific Collaboration

The final model is determined case by case, based on the product, regulatory status, manufacturer strategy, documentation, market feasibility, and the responsibilities each party is prepared to undertake.

Partnership process

A clear sequence for evaluating cooperation

  1. Initial Introduction

    The parties share objectives, product context, and the reason for considering the market.

  2. Product & Document Review

    Available technical, quality, regulatory, and commercial information is reviewed at an appropriate level.

  3. Market and Regulatory Assessment

    Key pathway questions, market conditions, dependencies, and areas requiring further evidence are identified.

  4. Partnership Structure

    Potential roles, responsibilities, commercial assumptions, and decision points are discussed.

  5. Pilot or Registration Planning

    Where justified, the parties define the next evaluation, pilot, documentation, or regulatory-planning activities.

  6. Launch Preparation

    An agreed plan addresses positioning, channel readiness, professional communication, supply coordination, and support.

  7. Ongoing Market Development

    The partnership reviews progress, feedback, constraints, and priorities without presuming a guaranteed outcome.

The sequence may change according to product classification, evidence, documentation, regulatory requirements, and the agreed scope. No approval, timeline, launch, or commercial result is guaranteed.

Partner fit

What we look for in a partner

A productive partnership begins with enough transparency and substance to evaluate the opportunity responsibly.

  • A credible product or technology that can be meaningfully evaluated
  • Technical and regulatory documentation available for review
  • Commitment to quality and a long-term working relationship
  • Readiness to adapt strategy to local market conditions
  • Appropriate scientific, educational, and commercial support
  • Transparency about pricing, supply capacity, and market rights

Business areas

Focused healthcare fields for potential cooperation

Explore the Right Path to the Iranian Healthcare Market

Share the product, technology, or market question you would like KTD to evaluate. The first conversation is used to understand fit, information needs, and a responsible next step.

Start a Partnership Conversation